Bee venom nanoparticles: Buzzworthy breakthrough in battling antibiotic-resistant bacteria

NewsGuard 100/100 Score

In a recent study published in Scientific Reports, researchers evaluated the antibacterial and cytotoxic effects of chitosan (CS) nanoparticles (NPs) loaded with bee venom (BV).

Study: Bee venom as an alternative for antibiotics against Staphylococcus aureus infections. Image Credit: Datenshutz-Stockfoto / Study: Bee venom as an alternative for antibiotics against Staphylococcus aureus infections. Image Credit: Datenshutz-Stockfoto / 

Exploring alternatives to antibiotics

Antibiotics may cause genetic changes in bacteria, leading to resistance against these compounds. In fact, every year, over 1.27 million deaths are attributed to antibiotic-resistant bacteria.

Staphylococcus aureus can cause skin abscesses, pneumonia, as well as joint and bloodstream infections, whereas its antibiotic-resistant strains are capable of causing even more severe outcomes. Thus, exploring alternatives to antibiotics, such as essential oils, natural products, and venoms, is imperative.

BV is a colorless, odorless, bitter, acidic liquid containing several active molecules. BV has anti-inflammatory and antimicrobial properties and is used for many diseases ranging from cancer and rheumatoid arthritis to Alzheimer's.

Nevertheless, the therapeutic potential of BV is limited by a specific dosage that, when exceeded, results in cytotoxicity. However, certain methods can be used to reduce or eliminate cytotoxicity associated with BV, such as gamma irradiation and NPs.

About the study

The present study examined the cytotoxic and antibacterial effects of native BV, BV-loaded CS-NPs, gamma-irradiated BV, and CS-NPs. BV from Apis melifera was obtained, half of which was irradiated at 0.7 kiloGray per hour (KGy/hr). The ionic gelation method was used to prepare CS-NPs and BV-loaded CS-NPs.

Fourier-transform infrared (FTIR) spectroscopy examined differences in functional groups between free BV, CS-NPs, irradiated BV, and BV-loaded CS-NPs. Transmission electron microscopy (TEM) was used to determine the particle size and morphology of NPs. Bradford protein assay was performed to assess encapsulation efficiency.

Photon correlation spectroscopy was performed to analyze the particle size and size distribution of NPs. The in vitro release rate of BV-loaded CS-NPs was also determined. The antibacterial effect against S. aureus was evaluated by the disc diffusion method.

The in vivo experiment involved mice being infected with bacteria through intraperitoneal administration, followed by treatment after three hours at a dose of 9.02 μg/g mouse weight.

Mice were categorized into 11 groups under different experimental conditions. These included non-infected animals receiving phosphate-buffered saline (PBS) as the negative control, native BV, irradiated BV, CS-NPs, or BV-loaded CS-NPs. Infected mice groups included no treatment and those treated with native BV, irradiated BV, CS-NPs, BV-loaded CS-NPs, or sulbacef, a commercial antibiotic.

Mice were euthanized after one week. Blood/serum specimens were collected for hematological and biochemical analyses. Additionally, liver, thymus, spleen, and kidney sections were obtained for hematoxylin and eosin staining and examination under a light microscope.

Study findings

BV exhibited typical peaks on the FTIR, which is characteristic of natural venom, with significant peaks at 3,400 cm-1 and 2,940 cm-1. Irradiated BV had similar peaks but with some alterations and at a lower intensity.

CS-NP spectrum was characterized by bands at 3,500-3,300 cm-1, 1,633 cm-1, and 1,150 cm-1. BV-loaded CS-NPs produced a sharp distinctive band at 1,642 cm-1.

The mean size of BV-loaded CS-NPs and CS-NPs was 175.85 nanometers (nm) and 24.03 nm, respectively. The zeta potential of BV-loaded CS-NPs decreased; however, the polydispersity index increased relative to CS-NPs. The encapsulation efficiency of BV-loaded CS-NPs was 96.44% at an optimal concentration of 2 mg/ml of CS and 550 μg/ml of BV.

The release of BV from BV-loaded CS-NPs increased until 30 hours and subsequently decreased after that. Treating infected mice with free or irradiated BV decreased leukocytes and increased platelets, whereas antibiotic treatment of infected mice increased platelets. All treatment groups increased urea, creatinine, aspartate transferase, and alanine transaminase levels relative to the control.

The rise in these parameters was similar between BV-loaded CS-NP and antibiotic treatments. Infected mice treated with native/irradiated BV or CS-NPs had elevated levels of interleukin-6 (IL-6), whereas treatment with BV-loaded CS-NPs reduced IL-6 levels. Infected mice exhibited varying levels of kidney damage, with CS-NP-treated animals exhibiting the highest damage.

Spleen sections of non-treated infected mice had congested blood sinusoids, excess giant cells, and scattered apoptotic cells. The congestion decreased upon treatment with irradiated BV or CS-NPs and disappeared with native BV, antibiotic, or BV-loaded CS-NP treatments.


BV-loaded CS-NPs exhibited superior antibacterial activity compared to native or irradiated BV without eliciting an inflammatory or cytotoxic response. These findings suggest that BV-loaded CS-NPs could be a potential therapeutic candidate and viable alternative to antibiotics. 

Journal reference:
  • Sameh, A., Gouda, A. A., Elmligy, E., et al. (2023). Bee venom as an alternative for antibiotics against Staphylococcus aureus infections. Scientific Reports. doi:10.1038/s41598-023-33536-x
Tarun Sai Lomte

Written by

Tarun Sai Lomte

Tarun is a writer based in Hyderabad, India. He has a Master’s degree in Biotechnology from the University of Hyderabad and is enthusiastic about scientific research. He enjoys reading research papers and literature reviews and is passionate about writing.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sai Lomte, Tarun. (2023, April 24). Bee venom nanoparticles: Buzzworthy breakthrough in battling antibiotic-resistant bacteria. News-Medical. Retrieved on May 21, 2024 from

  • MLA

    Sai Lomte, Tarun. "Bee venom nanoparticles: Buzzworthy breakthrough in battling antibiotic-resistant bacteria". News-Medical. 21 May 2024. <>.

  • Chicago

    Sai Lomte, Tarun. "Bee venom nanoparticles: Buzzworthy breakthrough in battling antibiotic-resistant bacteria". News-Medical. (accessed May 21, 2024).

  • Harvard

    Sai Lomte, Tarun. 2023. Bee venom nanoparticles: Buzzworthy breakthrough in battling antibiotic-resistant bacteria. News-Medical, viewed 21 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Drug repurposing breakthrough: varespladib curbs snakebite-induced necrosis